News Snapshot:
The pandemic had a negative effect on clinical research across all countries, but the UK seems to be taking longer than others to recover, according to a report from the Association of the British Pharmaceutical Industry (ABPI). The industry body maintains however that the UK can bounce back strongly if it adopts the innovative approaches taken to fighting COVID-19 – including regulatory flexibilities, digital and remote approaches, and innovative design and delivery models – and make sure clinical research is embedded into the NHS. The UK emerged as a major world force in COVID-19 studies, running 68 trials that positions...
